PAM (Pregnancy Associated Malaria), Related Problems and Its Effective Treatments


Malaria is one of the leading causes of death and disease worldwide, especially in the developing world. Malaria which is transmitted by anopheles mosquitoes is a preventable and treatable infectious disease. It kills more than one million people each year, mostly in sub-Saharan Africa and other endemic areas. We have conducted a survey in different maternity homes to check the rate of occurrence of malaria during pregnancy and its complications in pregnant women, fetus and new born. Medical reports of 100 patients have been studied and analyzed for this purpose. Here we conclude that malaria can be prevented, diagnosed and treated with a combination of available tools and sustained financing in these pregnant ladies. A comprehensive approach consisting of protective nets, indoor spraying with insecticide, preventive treatment for pregnant women, diagnostic tests, effective drugs, education, research and advocacy is needed to combat malaria. The major complication that occurs in expectant female is anemia, and the major complication that occurs in newborns is cerebral hemorrhage. The best and advanced treatment used most commonly nowadays for malaria is Artesunate & its combinations.

Share and Cite:

Gul, S. , Khan, T. , Naz, S. and Khan, T. (2014) PAM (Pregnancy Associated Malaria), Related Problems and Its Effective Treatments. Open Access Library Journal, 1, 1-6. doi: 10.4236/oalib.1100393.

Conflicts of Interest

The authors declare no conflicts of interest.


[1] Mishra, S.K. and Newton, C.R. (2009) Diagnosis and Management of the Neurological Complications of Falciparum Malaria. Nature Reviews Neurology, 5, 189-198.
[2] Schantz-Dunn, J. and Nour, N.M. (2009) Malaria and Pregnancy: A Global Health Perspective. Reviews in Obstetrics and Gynecology, 2, 186-192.
[3] Centers for Disease Control and Prevention (2010) The Rapid Assessment of the Burden of Malaria during Pregnancy: A Toolkit.
[4] Sangaré, L.R. and Stergachis, A. (2010) Determinants of Use of Intermittent Preventive Treatment of Malaria in Pregnancy: Jinja, Uganda. PLoS One, 5.
[5] Nosten, F., McGready, R. and Mutabingwa, T. (2007) Case Management of Malaria in Pregnancy. The Lancet Infectious Diseases, 7, 118-125.
[6] Conroy, A.L., McDonald, C.R. and Kain, K.C. (2012) Malaria in Pregnancy: Diagnosing Infection and Identifying Fetal Risk. Expert Review of Anti-Infective Therapy, 10, 1331-1342.
[7] Rijken, M.J., McGready, R., Boel, M.E., et al. (2012) Malaria in Pregnancy in the Asia-Pacific Region. The Lancet Infectious Diseases, 12, 75-88.
[8] Brabin, B.J. (1983) An Analysis of Malaria in Pregnancy in Africa. Bull World Health Organ, 61, 1005-1016.
[9] Takem, E.N. and D’Alessandro, U. (2013) Malaria in Pregnancy. Mediterranean Journal of Hematology and Infectious Diseases, 5.
[10] Desai, M., ter Kuile, F.O. and Nosten, F. (2007) Epidemiology and Burden of Malaria in Pregnancy. The Lancet Infectious Diseases, 7, 93-104.
[11] Kane, E.G. and Taylor-Robinson, A.W. (2011) Prospects and Pitfalls of Pregnancy-Associated Malaria Vaccination Based on the Natural Immune Response to Plasmodium falciparum VAR2CSA-Expressing Parasites. Malaria Research and Treatment, 2011, 21 p.
[12] McDonald, C.R., Elphinstone, R.E. and Kain, K.C. (2013) The Impact of Placental Malaria on Neurodevelopment of Exposed Infants: A Role for the Complement System? Trends in Parasitology, 29, 213-219.
[13] Centers for Disease Control and Prevention (2012) Intermittent Preventive Treatment of Malaria for Pregnant Women (IPTp).
[14] (2011) Global Fund Proposal Development: WHO Policy Brief on Malaria—WHO/GMP.

Copyright © 2024 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.